金沙中国23Q3复苏明显,EBITDA margin持续上升
–Clear path to margin recovery; Upgrade to BUY
3QFY23 margin beat on cost control; Upgrade to BUY
Both sales and margin recovery are on track
Macro uncertainty to impact revenue growth and margin outlook
BYD Company (1211 HK) 4Q22 beat; FY23E margins likely overestimated
–Expecting upbeat margin on better ARM
Kuaishou (1024 HK) Solid 4Q22E with better margin outlook
Structural margin improvement trend intact
–Proactive competitive strategy may weigh on nearterm margin but benefit LT growth